http://rdf.ncbi.nlm.nih.gov/pubchem/reference/15456019

Outgoing Links

Predicate Object
contentType Clinical Trial, Phase I|Journal Article|Randomized Controlled Trial|Research Support, Non-U.S. Gov't
endingPage 942
issn 1098-6596
0066-4804
issueIdentifier 2
pageRange 935-942
publicationName Antimicrobial Agents and Chemotherapy
startingPage 935
bibliographicCitation Bruderer S, Hurst N, de Kanter R, Miraval T, Pfeifer T, Donazzolo Y, Dingemanse J. First-in-humans study of the safety, tolerability, and pharmacokinetics of ACT-451840, a new chemical entity with antimalarial activity. Antimicrob Agents Chemother. 2015 Feb;59(2):935–42. PMID: 25421475; PMCID: PMC4335896.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ae2bc5f5c154a832328c8acc7a5979c9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_db2ab8e85f776afbe91a6f77ad8c4932
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_48b6abe681168e7f815bb4b34c203c19
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_97c16895c50df13c78f84cb0edab4021
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a7c32e9cb6398b9de65f082f7a62654c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f980e1799454811a02ae0e0a456b2b0c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-7503-9776
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b1b0de78512cf504be9dafa6397c33a6
date 201502
identifier https://doi.org/10.1128/aac.04125-14
https://pubmed.ncbi.nlm.nih.gov/PMC4335896
https://pubmed.ncbi.nlm.nih.gov/25421475
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/686
https://portal.issn.org/resource/ISSN/1098-6596
https://portal.issn.org/resource/ISSN/0066-4804
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title First-in-Humans Study of the Safety, Tolerability, and Pharmacokinetics of ACT-451840, a New Chemical Entity with Antimalarial Activity
discusses http://id.nlm.nih.gov/mesh/M0016884
http://id.nlm.nih.gov/mesh/M000632319
http://id.nlm.nih.gov/mesh/M0001469
http://id.nlm.nih.gov/mesh/M0000268
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D000962Q000009
http://id.nlm.nih.gov/mesh/D000178Q000009
http://id.nlm.nih.gov/mesh/D000962Q000493
http://id.nlm.nih.gov/mesh/D010879Q000009
http://id.nlm.nih.gov/mesh/D010879Q000493
http://id.nlm.nih.gov/mesh/D000178Q000493
hasSubjectTerm http://id.nlm.nih.gov/mesh/D004311
http://id.nlm.nih.gov/mesh/D004562
http://id.nlm.nih.gov/mesh/D000293
http://id.nlm.nih.gov/mesh/D000328
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D055815
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53303762
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10799

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID375973212

Total number of triples: 49.